
Was Alexander the Great really poisoned? Science sheds new light on an age-old question.
The sick Alexander (Alessandro infermo), by Domenico Induno, 19th Century, oil on canvas. Alexander drinks from a cup to show his trust in the doctor who gave it to him and condemns Parmenione who told him he would be poisoned. This event was said to take place in 333 B.C., 10 years prior to Alexander's death. Photograph by Sergio Anelli / Mondadori Portfolio, Getty Images
The young conqueror fell suddenly and fatally ill at an all-night feast. Now, a Stanford historian has found a potential culprit.
In June 323 BCE, in the palace of King Nebuchadnezzar II in Babylon, the most powerful man in the world died. Just 13 days earlier, Alexander the Great—the greatest conqueror the world had seen—had been drinking at one of his many all-night banquets when he suddenly cried out in pain. He was sent to bed suffering from abdominal pain and a fever, and over the following days his condition deteriorated. He suffered from weakness, thirst, possible convulsion, pain, partial paralysis and dozed in and out of consciousness. Towards the end he slipped into a death-like state and was unable to speak or move.
For six days after his death, the body of Alexander the Great showed no signs of decomposition. To the ancient Greeks it was a sign that Alexander was more god than man. To everyone else, for more than 2,000 years, the cause of his death and his body's preservation has been a mystery. Despite numerous theories, and a great deal of speculation, the death of the 32-year-old Alexander has been one of history's greatest cold cases. Fragment from the "Alexander Mosaic" showing Alexander the Great in battle against Persian King Darius III. (From a Roman copy of a Hellenistic painting.) Photograph by Universal History Archive, Getty Images
Even in antiquity people debated the cause of Alexander's death. Some thought it was caused by illness or infection, but throughout the ages, many historians from Pliny to Voltaire suspected foul play. The conspiracy to murder Alexander, wrote Diodorus, 'was suppressed by the power of Alexander's successors.'
Those who suspected poisoning even claimed to know the toxin at work: Roman intellectual Pausanias (2nd century CE) wrote of the 'lethal power' of the River Styx and added that he had heard it said that water from the Styx 'was the poison that killed Alexander.' Others, including Plutarch a biographer of Alexander, even claimed that it was Alexander's former teacher, the philosopher Aristotle, who provided the fatal dose. Apparently, Aristotle feared the man that Alexander had become. (Whatever else happened Aristotle is undeniably innocent—he was in Athens at the time of Alexander's death).
(How suspicion and intrigue eroded Alexander the Great's empire)
It is here that history appears to bleed into mythology. To moderns, the River Styx is best known from legends about the underworld. According to numerous ancient myths, the souls (or shades) of the deceased have to cross the River Styx on their way to Hades. But the Styx was not only a portal to the underworld, it was also a real place. Based on ancient accounts and modern investigation, the Styx has been securely identified as the Mavroneri (Black Water), a tributary of the Karathis River that empties into the Corinthian Gulf.
Why would people think that the waters of the Styx were poisonous and that this poison was used to assassinate Alexander the Great? In a new article, published in Geoheritage, Adrienne Mayor, a renowned research scholar in Classics and History of Science at Stanford, decided to investigate. Bulgaria's cultural capital
Many people in antiquity recognized the noxious properties of the River Styx. Plato refers to the 'fearful powers' of the Styx, the geographer Strabo described it as 'deadly water,' and the natural historian Pliny said that 'drinking [the water] causes immediate death.' The waters of the Styx were even thought to corrode metals and ceramic containers. As late as the 1860, when famed German naturalist Alexander von Humboldt commented on the Styx, he remarked that the stream has an 'evil reputation' among the 'present inhabitants' of the region. Even in the twentieth century locals avoided drinking from the stream and complained that it corrupted clay vessels.
Poisonous waters were well known in antiquity—one mentioned in the Bible was used as part of a truth trial for potentially adulterous women—but this fact alone does not explain the Styx's dark and persistent reputation.
(Were Alexander the Great and Hephaestion more than friends?)
Mayor, a historian of ancient science, wanted to understand how the mythology of the Styx's waters had developed. She told National Geographic that the project was years in the making. As someone who has specialized in unearthing the genuine natural knowledge embedded in ancient legends, the project was something of a natural fit. Fifteen years ago, in 2010, Antoinette Hayes, a pharmaceutical toxicologist, told Mayor about the possibility of a toxic crust that forms on limestone, and a recent report on the mass death of an elk herd after eating toxic lichen that piqued Mayor's imagination.
Together with the assistance of geologists, chemists, toxicologists and other scientists, Mayor began to investigate the possibility that in antiquity the Styx harbored naturally occurring toxins. In the resulting article and her forthcoming book Mythopedia: A Brief Compendium of Natural History Lore, Mayor argues that the limestone-lined pools of the Styx are 'ideal for harboring two extremely lethal natural substances, both only recently discovered by science: calicheamicin and toxic lichen.'
(Alexander the Great's warrior mother wielded unprecedented power) Calicheamicin from limestone
Calicheamicin is a crusty deposit that precipitates out of limestone, particularly in places where water drips, pools, and evaporates. As Mayor notes in her article, 'These are the conditions described by ancient observers of the rock-ringed pool by the Styx/Mavroneri waterfall. The water that flows through limestone is charged with calcium carbonate, which deposits hardened caliche crusts on rock surfaces, moss, and lichen' It can also form crusts on metal or clay (which might explain the myths about corroding vessels).
A number of organisms are known to colonize the surface of caliche. Some, like algae, are comparatively harmless. Others, like cyanobacteria, are 'neurotoxic, hepatotoxic, cytotoxic, and endotoxic at levels very dangerous to humans and animals.' In the 1980s a toxicologist collected a sample of caliche in Texas that led to the discovery of calicheamicin, a toxic substance that has been used to develop potent antibody-targeted chemotherapy but in its original form has a 'cellular lethality greater than that of ricin.' We cannot say for certain if it was present in antiquity at the limestone rimmed pool of the Styx. A great deal depends on the presence—in antiquity—of the proper nutrients and soil conditions for its growth. Depending on the dose, mortality from a substance like this would 'probably take days or weeks due to the toxic mechanisms of DNA destruction.' This process would ultimately have led to multiple organ failure. Because it dissolves in alcohol it would have been the perfect poison to slip into Alexander's drinking vessel at a banquet.
(Alexander the Great had daddy issues) Oxalic acid from lichen
Mayor also posits a second soil-based toxin that may have been collected from the limestone rock ledges and pools of the Styx. Many fungi, molds and lichens produce toxic mycotoxin. While the harmful effects of certain species of mushrooms have been well known for centuries, until relatively recently lichen were thought to be benign. A recent study noted by Mayor discovered that 'one in eight species of lichens contain…poisons [microcystins] that cause liver damage.' Because ancient people did not recognize lichen as distinct from host trees and rocks, they were not identifiable as a source of poisoning. If goats died at the River Styx, as the ancient geographer Pausanias says that they did, 'water,' writes Mayor, 'might be logically identified as the culprit, rather than the rocks on the banks.'
The most common lichen forming fungi on limestone in this region, Mayor writes, are 'black meristematic aureobasidium-like and Penicillium-like species, which can be highly toxic when ingested by animals and humans.' The fact that lichenizing fungi produce a black patina on rocks recalls the use of the adjective 'black' in description of the Styx. These fungi also excrete toxic oxalic acid, which is highly corrosive. This, too, might explain the rumors that the waters of the Styx destroyed metal. Today, oxalic acid used to dissolve rust. The roots of a legend
'The results of ingesting [either of these] these substances,' Mayor says, 'would have been observed and remembered over generations.' Even if only a few animals and people died, the memory of the events would have added to the ancient lore surrounding a river already saturated with myths about the underworld.
In the aftermath of Alexander the Great's death, says Mayor, 'I think it was reasonable for Alexander's companions to believe that he had been poisoned—many in his circle had motives and opportunities. And his detailed symptoms match those long associated with Styx water.' Mayor stressed that her study does not solve the debate over the death of Alexander the Great. For that, she noted, we need a time machine and a toxicological autopsy.
The problem is ultimately unsolvable. Scientists could test the waters of the Styx/Mavroneri today for calicheamicin and lichen but their findings—whether positive or negative—would not tell us if these poisons were present in the stream in antiquity.
What Mayor's study does explain is why people thought Alexander had ingested the waters of the Styx. Once members of his circle decided that Alexander had been poisoned, they identified the poison with the River Styx because, like Alexander, the River Styx was the stuff of legend. After the association was made, people began to narrate his death with this idea in mind.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 hours ago
- Yahoo
A scientific breakthrough researchers call ‘magic' could transform treatment for a leading cause of death
For all of the advancement in treating stroke victims over the past couple of decades, some concerns have remained almost constant. In medicine, we like to say that 'time is brain,' meaning that every moment a stroke goes untreated, the potential for long-term brain damage or death escalates. In fact, every minute that the brain goes without blood flow, the average patient loses around 1.9 million neurons and about a week of independent life, experts say. As the vast majority of strokes are ischemic, with a blood clot blocking the flow of oxygen to the brain, clearing that clot swiftly is critical. This is true whether the clot is small or large and regardless of its density—but reliably removing the densest clots via mechanical means has proved an elusive task. Though these concerns, time and density, are not necessarily linked, both matter—one reason, researchers suggest, that a newly developed technology from Stanford University holds the potential to reshape how stroke patients are treated. The device, called a milli-spinner, is a tiny, powerfully rotating hollow tube outfitted with fins and slits. In action, both lab and swine tests demonstrate the ability to dramatically compact and shrink the size of blood clots, making it easier to remove them quickly and effectively—often on the first try. 'This has the potential to be a game changer,' says Greg Albers, director of the Stanford University Stroke Center and a longtime expert in the field. 'The results are likely to translate well to clinical trials.' Mechanical thrombectomy is a minimally invasive procedure by which blood clots are removed. Existing thrombectomy methods, which involve aspirating clots via a catheter or trying to grab and remove them through a stent, are not designed primarily to reduce the size of blood clots. The milli-spinner appears to do so almost routinely—and very quickly, sometimes in a matter of seconds. In a paper published June 4 in the scientific journal Nature, the milli-spinner boasted some audacious early numbers. In flow model tests and swine experiments, the thrombectomy device, inserted via a catheter, demonstrated the capacity to shrink clots by up to 95%. 'For most cases, we were more than doubling the efficacy of current technology' in terms of opening the artery, says Dr. Jeremy Heit, MD, PhD, chief of neuroimaging and neuro-intervention at Stanford and coauthor of the study. Placed close to a clot, the milli-spinner exerts both compression and shear forces to release red blood cells from the sometimes-dense fibrin that has bound it in a clump—a somewhat unexpected development when it was first observed in the lab, says Renee Zhao, the Stanford engineer who designed the milli-spinner and was lead author of the Nature study. 'It was magic to us, because even after we saw the phenomena, it was not very straightforward to directly figure out the working mechanism,' Zhao tells Fortune. A fibrin core remains tightly bound around the milli-spinner, but it is now dramatically smaller than before, and easily removable. (Imagine placing some cotton candy in your hand and then closing your fist tight.) 'What's crazy is, it works in seconds—it literally will spin this thing into a tiny clot and just suck it into the catheter in seconds,' says Heit. 'It's incredibly fast.' Much work remains, the researchers say, including full-scale human trials. But if the results are even close to what's been achieved in the lab and swine work, the device could alter the treatment path for an all-too-common, all-too-serious medical issue. Strokes are the fifth-leading cause of death in the U.S., with about 160,000 deaths a year among the nearly 800,000 cases diagnosed annually. Roughly nine in 10 strokes are ischemic, or clot-related. Patients with ischemic strokes are often treated with clot-busting drugs like tPA or thrombectomy (sometimes both), but the mechanical techniques still encounter failures. In some cases, a clot is simply too large to be extracted by a stent or aspiration device, or it may be too firmly adhered to a vessel wall. In others, because clots are crumbly, small bits may break off during the retrieval attempt. The blood flow can take them further into the brain, potentially making the size of a stroke bigger or causing a new deficit, says Heit. 'Both aspiration and stent retrievers have a high risk of generating fragmentation,' Zhao says. 'The milli-spinner actually prevents it from happening,' at least in the lab. Current thrombectomy devices successfully remove clots less than 50% of the time on the first try, and in about 15% of cases they fail altogether, experts say. It's important because people in whom the blockage is removed on the first attempt with thrombectomy have better clinical outcomes than those who require multiple passes. 'The outcomes are much better than if it takes you two, three, four tries to get everything open,' says Maresh Jayaraman, chair of diagnostic imaging at Brown University. 'Obviously, we need to know that (the milli-spinner) can be safe and effective in humans. If it is, it has the potential to dramatically revolutionize how we think about removing blood clots from the brain.' Zhao says she and her colleagues weren't actually trying to solve this issue, at least not initially. Rather, the engineer had been working on millirobots—tiny, origami-based spinning devices capable of swimming untethered through the bloodstream. Propelled by an external magnetic field, the millirobots, which are still in development, may be able to deliver medicine to targeted regions in the body, perform diagnostic tasks, or perhaps one day even carry instruments or cameras. The spinning millirobots generate 'a highly localized, very strong suction,' says Zhao. 'We were thinking, okay, can we use that suction to suck a clot? It was just extremely simple—I mean, a very straightforward way of thinking.' In the cerebral artery flow model in the lab, Heit says, the milli-spinner was 100% effective at removing clots in more than 500 attempts. In pigs, the device restored at least half of blood flow to blocked blood vessels 90.3% of the time on the first try, nearly twice the average achieved by aspiration. And it was nearly fourfold better at completely opening the artery for the toughest clots. 'I expect (the device) to be a sea-change in technology for the treatment of acute ischemic stroke patients,' Heit says. 'If blood clots are removed at the high success rates in humans as they are in our experiments, which we expect to be the case, the milli-spinner will save tens of thousands of lives or more, and substantially reduce disability in treated patients.' Human clinical trials are the next step. Areas to watch, says Arthur Adam, a neurosurgeon and stroke expert at University of Tennessee Health Sciences Center, include how human brain tissue is affected by the new thrombectomy method, and how the cells and debris behave once they're liberated from the fibrin by the milli-spinner. 'Human trials are essential, and they sometimes show very different results than what we see in early results,' says Adam. Still, the development appears promising. 'It is a very exciting new device, with great potential,' says Colin Derdeyn, chair of radiology and medical imaging at the University of Virginia School of Medicine. 'If it performs in people as well as it does in these models, it will improve recanalization rates—how frequently we are able to open a blocked artery in the brain, heart, or lung. This will lead to better outcomes in patients with stroke, heart attack and pulmonary embolism.' It may also represent only the front end of the technology. Zhao and her colleagues think the untethered, robotic version of the milli-spinner will be able to swim directly inside blood vessels to treat blood clots, brain aneurysms, kidney stones, and other conditions. In the meantime, the team has formed a company in California to proceed with clinical trials on the milli-spinner. 'Considering the growing patient pool and this very promising technology, I think we can potentially save a lot of patients' lives,' Zhao says. 'We want to see this technology in humans—and the sooner, the better.' This story was originally featured on

Miami Herald
20 hours ago
- Miami Herald
A growing number of shoppers are avoiding this ingredient
Trying to keep up with food and wellness trends feels like a full-time job. It started with organic. Then came gluten-free. Then vegan, non-GMO, Whole30, name it. Grocery store shelves are now a sea of claims, labels, and certifications, each one shouting for attention and promising to be the "cleaner," "better," or "safer" option. Shoppers are flipping packages over, scanning ingredient lists, and thinking twice before tossing something in the cart. Related: Heinz announces a genius new product fans will love They're not just looking for what a product has. They're zeroing in on what it leaves out. And now, a new category of ingredients is getting side-eyed. It's not sugar, gluten, or carbs this time. It's something that weaseled its way into everything from salad dressing to snack that was easy to miss, until now. That rising skepticism paved the way for a new kind of label, one that's now quietly changing what ends up in people's carts. Image source: Getty Images The ingredient getting dragged? Industrial seed oils. Think: canola, soybean, sunflower, and corn. These weren't even part of the American diet a century ago. Now, they can make up over 20% of the average person's daily calories. You'll find them in everything: frozen meals, sauces, baked goods, even "healthy" snacks. They're cheap. They're stable. And they've quietly become a food industry favorite. But not everyone's convinced they belong in our food. Shoppers are starting to question their heavy refining, sky-high omega-6 levels, and ultra-processed vibes. To meet that growing concern, brands are now turning to Seed Oil Free Certified - a label that launched in 2023 but is gaining serious momentum in 2025. Related: Forget the ice cream man, try this healthy take on a summer treat It's the first official certification for products made without industrial seed oils. And the brands who jumped on board are already reaping the benefits. According to a press release, Seed Oil Free Certified products saw a 216% sales spike in Q1 2025 compared to the year prior. Even more eye-popping, these products made a 410% jump in just the most recent 12-week period. And that growth isn't limited to niche wellness aisles. Sales are booming in both natural and conventional retail. What started as a quiet movement is quickly becoming a shelf-shaking trend. For shoppers, the seal keeps things simple. For brands, it's a fast track to standing out. According to the Seed Oil Free Alliance, certified brands are seeing stronger customer interest, better shelf velocity, and real traction with ingredient-conscious buyers. "We've seen firsthand the positive impact it has had on our brand," said Daily Crunch Co-founder Laurel Orley. More on retail: Starbucks changes drink prices (you might like it)Iconic Disney theme park treat comes to grocery storesGeneral Mills makes huge change to your favorite cereals "Displaying the Seed Oil Free Certified seal on our packaging helps customers identify Daily Crunch as a product aligned with their values." And those values are driving real decisions. A recent nationwide survey found that 28% of U.S. consumers are now actively trying to avoid seed oils. They're looking for simpler ingredients, less industrial processing, and more transparency. For brands, it's not just about putting a new label on the front. It's about building trust in an aisle full of noise. And the numbers don't lie: shoppers are buying in. A full list of Seed Oil Free Certified products can be found at Related: The diet mistake 71% of Americans are trying to fix The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.


San Francisco Chronicle
20 hours ago
- San Francisco Chronicle
There's been a stunning drop in heart attack deaths — but these other risks are rising
Deaths from heart attacks have fallen dramatically over the past 50 years, even taking into account a short but sharp increase in mortality during the COVID-19 pandemic, in a testament to the remarkable medical investment made by the U.S. to counteract a deadly public health threat, say teams of scientists from UCSF and Stanford who released parallel reports this week. Heart attack deaths dropped by nearly 90% from 1970 to 2022, the time period that the Stanford team studied for their report published in the Journal of the American Heart Association. That's a direct result of immense investment in tools to prevent, test for and treat cardiovascular conditions, in particular heart attacks, said Dr. Latha Palaniappan, senior author of the Stanford paper. 'A 90% reduction in heart attack deaths over the last 50 years is nothing short of a medical miracle,' Palaniappan said. In the paper, Palaniappan and her peers noted that nearly half of global funding for heart disease research comes from the U.S., which 'has had an incredible return on investment.' 'This investment has driven global breakthroughs and continues to shape how we prevent and treat heart disease worldwide,' Palaniappan said. 'These breakthroughs have helped increase life expectancy in the U.S. by a full decade since the 1970s.' On the other hand, progress has flagged in fighting deaths from other types of cardiovascular issues, including high blood pressure, heart failure and arrhythmia, according to both studies. Overall cardiovascular mortality from non-heart attacks increased by about 80% over the past 50 years. Both the Stanford and UCSF studies analyzed heart disease deaths using data from the Centers for Disease Control and Prevention. The studies noted sharp increases in heart attack deaths during the pandemic — peaking at about 93 of every 100,000 deaths in 2021 — that have since fallen to pre-pandemic levels. Heart disease has been the leading cause of death among Americans for more than a century. The term describes a wide range of conditions, including coronary artery disease, the main contributor to heart attacks, along with heart failure, heart rhythm disorders and hypertension. The drop in heart attacks comes from a multi-pronged effort, including public health campaigns such as smoking cessation efforts, and medical advances in prevention and treatment. According to the Stanford study, someone over age 65 who was hospitalized for a heart attack in 1970 had a 60% chance of leaving the hospital alive; today, they have a greater than 90% chance. But the drop in heart attacks has coincided with an increase in deaths caused by all other heart conditions. The UCSF study found that deaths from high blood pressure doubled from 1999 to 2023, the time period the scientists analyzed. Deaths from heart failure also climbed, hitting a record high in 2023. Part of the reason deaths from other types of heart disease are climbing is because people are generally living longer — the age expectancy increased by about a decade over the past 50 years. They're surviving heart attacks and then succumbing later to other, sometimes related conditions. Dr. Sanket Dhruva, senior author of the UCSF paper, said these conditions are all treatable and preventable. He said the data should compel the medical community to redouble efforts to battle all types of heart conditions — the immense progress made against heart attacks demonstrates what can be done with money and focus, Dhruva said. 'Really one of the key findings of our paper is where have the patterns been worsening,' Dhruva said. 'Death from cardiovascular disease is getting better over time, but it's not that simple. It's very nuanced. Death from hypertension diseases, and related to heart failure — those deaths are reaching record highs.' Dhruva said that for many of these conditions, tools already exist to improve outcomes for most patients — the work needs to focus on making sure those tools are accessible, and that the people who need them are being diagnosed and connected to treatment. For example, the U.S. needs to do a better job of screening for high blood pressure, then making sure people with high blood pressure have access to health care providers, medication and testing equipment. The UCSF paper found a precipitous increase in heart disease deaths during the pandemic, in large part because people's access to care was interrupted — folks stopped visiting their doctors, checking their blood pressure or even taking their medications. Some people stopped exercising, further increasing their risk. Though that care is getting back on track for most people, its absence should demonstrate how critical it is to maintain access. 'The pandemic halted decades of progress,' the UCSF paper noted. 'We know that people were not coming for care, we know that risk factors got worse,' Dhruva said. 'People gained weight, medication adherence slipped, people stopped seeing their care providers as often. Cardiovascular care got worse during the pandemic.' Still, he said, 'We learned a lot from the pandemic. We learned that it's absolutely necessary to ensure that patients are getting care.'